KIF18A inhibitors(Aurigene Oncology Ltd)

N/A

Report date: 2025/11/21 10:34:05

NME

Base Information

Drug NameKIF18A inhibitors(Aurigene Oncology Ltd)

Drug Alias NameN/A

ClassificationSmall molecules

Mechanisms of ActionKinesin-like protein KIF18A inhibitors

TargetsKinesin-like protein KIF18A

Therapy Area/IndicationsOvarian NeoplasmsBreast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryIndia

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsOvarian NeoplasmsBreast Neoplasms

Inactive IndicationsN/A

ATC CodeN/A